Leave your contact details and we will contact you
The cost of services is determined by their scope and content and is calculated upon request via email at info@rncph.ru
Home
Analytical databases
We produce accurate analytical tools
RNC Pharma provides partners with a wide range of syndicated projects on
the analyzed markets
Contact us
Contact us
About project
We provide 24/7 remote access from any part of the world through an intuitive and clear online interface
User access allows to construct reports of the required structure and upload them to users' devices in a table format (xlsx or csv). Clients have the access to a flexible system of user settings, including advanced search and filtering features, customizing and saving your own templates. RNC Pharma specialists provide the training for new users and operational support to customers when it is needed
Retail sales audit
This block of projects allows us to analyze operational processes that take place in the retail segment of the Russian pharmaceutical and related markets in order to conduct competitive analysis, monitor the effectiveness of marketing activities, evaluate the distribution levels of specific products, commodity neighborhood, size of the average check, etc.
Production of pharmaceuticals in Russia
The project allows estimating the actual output of specific products, including the launch of new drugs that have not entered the distribution system yet. It tracks import substitution trends, estimates the amount of actual demand for
active pharmaceutical ingredients, auxiliary substances and packaging materials
13.04.2026
Demand for choleretic drugs on the Russian retail pharmaceutical market demonstrated steady positive dynamics for three consecutive years. Throughout 2022–2025, both monetary and physical consumption volumes in the category grew confidently.
09.04.2026
The Russian retail market for breast milk substitutes reached RUB 54.1 billion in 2025 at retail prices, including VAT, with ruble growth of 11.3% compared to 2024.
08.04.2026
In 2025, total Russian spending on drugs used for varicose veins increased by 13.2% and exceeded RUB 37 billion. Unlike monetary sales volume, physical consumption continues to decline.
07.04.2026
In 2025, 66.2 million vials of tinctures were sold in Russian pharmaceutical retail, amounting to approximately RUB 4.4 billion.
02.04.2026
In January–February 2026, the Russian retail market for blood pressure monitors including e-commerce and the FMCG segment reached RUB 2.53 billion.
31.03.2026
The Russian retail market for saline- and seawater-based nasal and throat rinse products has shown steady multi-year growth, reaching RUB 15.2 billion by the end of 2025.
30.03.2026
The retail market for antidepressants continues to show rapid growth. In the first two months of 2026, Russians purchased over 4.1 million packages of the analyzed drugs, amounting to more than RUB 3.6 billion.
25.03.2026
In 2025, the Russian retail market for nebulizers (including marketplaces) amounted to RUB 4.6 billion. Over the past year, Russians purchased 2.1 million units of various types of inhalers.